CLEVELAND (AP) — Jo Adell had a career night and showed the power that made the Cleveland Guardians acquire him at the trade deadline.
However, in a season in which every good thing that happens to the Guardians ends up being followed by a setback, Adell’s night ended on a down note Tuesday.
Adell left before the eighth inning of the Guardians’ 8-1 victory over the San Francisco Giants due to a bruised left knee. He fouled a pitch off his left kneecap during the first inning before hitting a 455-foot, three-run homer three pitches later.
Adell was receiving treatment after the game and wasn’t available for comment after setting a career high with six RBIs and the longest homer of his seven-year career. He will continue to be evaluated.
“It seems like every time we go out and check on somebody, they do something pretty special,” manager Stephen Vogt said after the Guardians' win. “But Jo obviously fouled that ball off his knee pretty hard. That’s why we took him out of the game. He was feeling some pretty good pain as the game went on.”
Adell had his eighth three-hit game, but his first for the Guardians. He came into the game batting .167 (7 for 42) since being acquired by the Guardians at the Aug. 3 trade deadline.
“Adell was the issue, for sure, tonight. Adell was the problem -- and other guys hit us too,” Giants manager Tony Vitello said.
After Steven Kwan and José Ramírez got on base, Adell connected on an elevated changeup from Giants starter Carson Whisenhunt on a 2-2 count and the seventh pitch of the at-bat, depositing it five rows from the top of the bleachers in left field to give the Guardians a 3-0 lead.
Adell’s blast surpassed the 454-foot homer he hit in Kansas City last year while with the Los Angeles Angels for the longest of his career.
It also was the longest homer at Progressive Field since Kansas City’s Salvador Perez had a 457-foot shot in 2024. The last Cleveland player to go at least 455 feet was Bradley Zimmer (465 feet) in 2021 against Texas.
Adell also had a two-run single in the second and an RBI base hit in the fourth. He was the sixth player in the majors this season with at least six RBIs in the first four innings of a game, but the first Cleveland player since Ramírez in 2019.
“We haven’t seen very many balls fly that far to left field since I’ve been here, and his power’s real. But my favorite at-bat was the second one, two outs, second and third, right back up the middle for a two-run single,” Vogt said.
Adell’s injury is the latest in what has been a rough couple of days for the Guardians. Outfielder Chase DeLauter missed Tuesday’s game due to mild left hamstring tightness after playing only two innings during Sunday’s 5-0 loss to San Diego.
Cleveland (61-65) has gone 10-19 since the All-Star break and is one game behind Texas for the last wild-card spot in the American League.
“We’re pretty banged up on the position player side. So we got a lot of guys we’re monitoring,” Vogt said.
On June 13, the Guardians lost three players during the span of five innings against Detroit. Ramírez fractured the left hamate bone during an at-bat and missed more than five weeks; DeLauter bruised his right rib cage after colliding with the outfield wall and was sidelined for two weeks. Angel Martinez was out for six weeks after fouling a pitch off his left foot.
See AP’s full MLB coverage here
Cleveland Guardians' Jo Adell hits a three-run home run off San Francisco Giants starting pitcher Carson Whisenhunt during the first inning of a baseball game, Tuesday, Aug. 18, 2026, in Cleveland. (AP Photo/David Dermer)
Cleveland Guardians' Jo Adell is congratulated by Jose Ramirez (11) and Steven Kwan (38) after hitting a three-run home run off San Francisco Giants starting pitcher Carson Whisenhunt during the first inning of a baseball game, Tuesday, Aug. 18, 2026, in Cleveland. (AP Photo/David Dermer)
LONDON & MADRID--(BUSINESS WIRE)--Sep 15, 2026--
Axo Longevity today announced the close of an oversubscribed $5M seed round to expand its preventive health membership across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910642125/en/
The round was backed by MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital and NIAN Sports & Entertainment, alongside angel investors including Dr. Jorge Planas of Clinica Planas Barcelona and Daniel Kulle, former President of H&M and former CEO of Forever 21.
Developed to help people understand what is happening inside their body before symptoms appear, Axo Longevity moved from build to live operations in just twelve weeks. The platform is expanding globally, now operating in the United Kingdom, Ireland, Spain, Germany, and the Netherlands, as well as in its first Latin American market, Peru. It is supported by more than 1,400 laboratory locations through certified partners including Randox, Sussex Pathology, Eurofins, MDI Limbach and Multilab. More than 19,000 people have joined the waitlist.
Its core membership, called Axo Longevity Care, costs 490 euros a year and includes two comprehensive blood panels analysing 100+ biomarkers each time, with an Axo Health Score and biological age, and personalised health plans. Membership starts from 190 euros a year. Members book a blood draw at a partner laboratory, receive results measured against optimal ranges rather than population averages, and retest six months later to track what has changed.
"I looked healthy. I trained, I ate well, I had no symptoms. If I had graded my health from one to ten, I would have said nine. In reality I was closer to a six," said Andrew McCarthy, Co-founder and CEO of Axo Longevity. "A full biomarker panel showed cardiovascular risk indicators that would have gone undetected for years. We’re building a service for what happens after the test."
Axo Longevity’s clinical team is led by Chief Medical Officer Dr. Niko Mihic, Medical Supervisor at Real Madrid FC, former Head of NBA Research in Europe and NFL Europe Medical Consultant, who was named by Forbes as one of Spain's 25 most influential healthcare providers. Andy Walshe, PhD, Executive Longevity Advisor, is the former Head of High Performance at Red Bull and currently advises the US, UK and Australian Olympic teams.
"Consumer health companies usually fail on operations, not on science," said Jon Soberg, CEO and Managing Partner of MS&AD Ventures. "Axo Longevity is live in six countries with Europe’s largest working laboratory network and members returning for repeat testing. That kind of infrastructure and engagement is much harder than launching a single market - and that’s exactly the kind of execution we look for."
Axo Longevity’s advisors include Michael Johnson, twelve time Olympic and World Champion; Mario Schlosser, co-founder of Oscar Health; Eric Solomon, former top exec at Google, YouTube, Spotify and Instagram; and Rosa Hamalainen, who helped scale Rupa Health.
"Europe has exceptional clinical infrastructure, but for consumers it is fragmented, and they might only be able to access it when they are sick," explains Sergio Tang, Co-founder and Chief Product and Growth Officer. "We are delivering a single membership experience that works seamlessly and equips people with a data-driven understanding of their health - and a clear action plan of exactly what to do next.
"This funding will allow us to grow our laboratory network, continue to develop our AI health copilot and wearable integrations, and expand our services into the Nordics, Italy and Portugal."
About Axo Longevity
Axo Longevity is a global preventive health membership, now operating in the United Kingdom, Ireland, Spain, Germany, and the Netherlands, as well as in its first Latin American market, Peru. Members receive comprehensive biomarker testing, a personalised health blueprint and ongoing tracking through Axo Longevity’s platform. Founded in 2025 by Andrew McCarthy, Sergio Tang and Octavia Seymour. Learn more at www.axolongevity.com
Imagery of the founders is available for download here.
Axo Longevity preventive health membership
